|
|
|
|
LEADER |
00000cam a2200000Mu 4500 |
001 |
EBOOKCENTRAL_on1257083911 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
210619s2021 xx o ||| 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|c EBLCP
|d N$T
|d OCLCO
|d OCLCF
|d OCLCO
|d LOA
|d K6U
|d OCLCQ
|d OCLCO
|d OCLCL
|d TMA
|d OCLCQ
|
020 |
|
|
|a 1681087847
|
020 |
|
|
|a 9781681087849
|q (electronic bk.)
|
029 |
1 |
|
|a AU@
|b 000072105421
|
035 |
|
|
|a (OCoLC)1257083911
|
050 |
|
4 |
|a RC394.T5
|
082 |
0 |
4 |
|a 616.99/4
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Thrombosis in Cancer
|h [electronic resource].
|
260 |
|
|
|a Sharjah :
|b Bentham Science Publishers,
|c 2021.
|
300 |
|
|
|a 1 online resource (134 p.)
|
500 |
|
|
|a Description based upon print version of record.
|
505 |
0 |
|
|a Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Overview of Cancer-Associated Thrombosis -- Prajwal Dhakal1,* and Nishraj Basnet2 -- INTRODUCTION -- EPIDEMIOLOGY -- PROGNOSIS AND IMPACT OF VTE IN CANCER PATIENTS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Pathophysiology and Risk Factors for Cancer-Associated Thrombosis -- Fawzi Abu Rous1,*, Layan A. Elkhatib2 and Prajwal Dhakal3 -- PATHOPHYSIOLOGY -- RISK FACTORS -- Tumor Related Factors -- Treatment-Related Factors -- Surgery -- Hospitalization -- Chemotherapy, Hormonal Therapy, and Radiotherapy -- Supportive Therapy -- Patient-Related Factors -- BIOMARKERS -- RISK MODELS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Impact of Venous Thromboembolism on Cancer Survival -- Manoj Rai1,* -- BACKGROUND -- INCIDENCE -- MORTALITY -- VTE RECURRENCE -- EFFECT OF ANTICOAGULATION IN CANCER -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Occult Cancer Workup in Idiopathic Venous Thromboembolism -- Manoj Rai1,* -- INTRODUCTION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chemotherapy Induced Thrombosis -- Manoj Rai1,* and Nishraj Basnet1 -- INTRODUCTION -- PATHOPHYSIOLOGY -- PROPHYLAXIS DURING CHEMOTHERAPY -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Catheter-Related Thrombosis in Cancer -- Prajwal Dhakal1,* -- INTRODUCTION -- EPIDEMIOLOGY AND RISK FACTORS -- PATHOPHYSIOLOGY AND TYPES OF CRT -- Pericatheter Sheath or Fibrin Sleeve -- Intraluminal Clot -- Mural Thrombus -- Other Causes -- CLINICAL PRESENTATION -- DIAGNOSIS -- TREATMENT -- Removal of Catheter -- Systemic Anticoagulation -- Other Options.
|
505 |
8 |
|
|a PREVENTION OF CRT IN CANCER PATIENTS -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Management of Cancer-Associated Thrombosis -- Lilit Karapetyan1,2, Calvin Abro2, Seda Grigoryan3 and Prajwal Dhakal1,* -- INTRODUCTION -- INITIAL TREATMENT -- Anticoagulants -- Low Molecular Weight Heparin -- Factor Xa Inhibitors -- Unfractionated Heparin -- Warfarin -- LONG TERM MANAGEMENT -- ROLE OF DIRECT ORAL ANTICOAGULANTS -- FINANCIAL ASPECTS OF CHOOSING ANTICOAGULATION -- MECHANICAL DEVICES -- Inferior Vena Cava Filters -- IMPACT ON SURVIVAL WITH ANTI-THROMBOTIC THERAPY -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Special Cases in Cancer-Associated Thrombosis -- Omar Albanyan1,* and Ikponmwosa Enofe1 -- INTRODUCTION -- VTE and Thrombocytopenia -- RECURRENT VTE -- VTE IN RENAL IMPAIRMENT -- INCIDENTAL VTE IN CANCER -- MYELOPROLIFERATIVE DISORDERS AND VTE -- BONE MARROW TRANSPLANTATION AND VTE -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Antitumor Effects of Heparin -- Samanjit Kandola1 and Manoj Rai1,* -- INTRODUCTION -- TYPES OF HEPARIN -- Unfractionated Heparin -- Low-Molecular-Weight Heparin -- Butanoylated Heparin -- EFFECTS OF HEPARIN ON TUMOR -- Anti-Angiogenesis Effects -- Antiproliferative Effects -- Effects on Immune System -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- VTE Prophylaxis -- Fawzi Abu Rous1, Manoj Rai1,*, Osama Mosalem1, Layan El-khatib2, Calvin Abro1 and Abdullah Al-abcha1 -- INTRODUCTION -- RISK STRATIFICATION -- INPATIENT VTE PROPHYLAXIS -- OUTPATIENT VTE PROPHYLAXIS -- PERIOPERATIVE VTE PROPHYLAXIS -- SOCIETY GUIDELINES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Subject Index.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Thrombosis.
|
650 |
|
0 |
|a Cancer
|x Complications.
|
650 |
|
2 |
|a Thrombosis
|
650 |
|
6 |
|a Thrombose.
|
650 |
|
6 |
|a Cancer
|x Complications et séquelles.
|
650 |
|
7 |
|a Cancer
|x Complications
|2 fast
|
650 |
|
7 |
|a Thrombosis
|2 fast
|
700 |
1 |
|
|a Rayamajhi, Supratik.
|
700 |
1 |
|
|a Dhakal, Prajwal.
|
700 |
1 |
|
|a Shrotriya, Shiva.
|
758 |
|
|
|i has work:
|a Thrombosis in Cancer (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCYkt6jhFBvbCxKtYjrXHfm
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|a Rayamajhi, Supratik
|t Thrombosis in Cancer: a Medical Professional's Guide to Cancer Associated Thrombosis
|d Sharjah : Bentham Science Publishers,c2021
|z 9781681087856
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=6640405
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL6640405
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 2938750
|
994 |
|
|
|a 92
|b IZTAP
|